Festal (pancreatin, hemicellulase, bile) tablets
31758USD

Festal (pancreatin, hemicellulase, bile) tablets

SKU:2994
To favorites
Festal (pancreatin, hemicellulase, bile) tablets for chronic pancreatitis, digestion disorders, flatulence, tendency to constipation, chronic gastritis, to improve digestion
Active substance:pancreatin, hemicellulase, bile
Pharmacological group:Gastrointestinal medications
Formulation:Tablets
Country of origin:India
In stock
$17
11
Description
Features
Reviews

Instructions for Festal (pancreatin, hemicellulase, bile) tablets

ATC Codes pancreatin
A09AA02 Multienzymes (lipase, protease etc.)

The drug should be stored out of reach of children at a temperature not exceeding 25 °C.
Clinical and pharmacological groups / Group affiliation

Digestive enzyme pancreatin
The drug should be stored out of reach of children at a temperature not exceeding 25 °C.

Active substance Festal

pancreatin 

The drug should be stored out of reach of children at a temperature not exceeding 25 °C.

Pharmacotherapeutic group

The drug should be stored out of reach of children at a temperature not exceeding 25 °C.
Shelf life is three years. Do not apply after expiry date indicated on the package.

Pharmacological effect Festal

Festal® replenishes the deficiency of enzymes of the pancreas and biliary tract. It is composed of pancreatin and bile acids, which provide proteolytic, amylolytic and lipolytic action. Pancreatine enzymes—amylase, lipase, and protease—promote the breakdown of carbohydrates, fats, and proteins, improving their absorption in the small intestine. The bile acids included in the drug help correct biliary insufficiency, which often accompanies chronic pancreatitis. They have a choleretic effect, facilitate the absorption of fats and fat-soluble vitamins A, E and K, and stimulate the production of lipase by the pancreas. Hemicellulase in the composition of Festal® promotes the breakdown of plant fiber, improves digestion and reduces gas production in the intestine.

Indications for use Festal

Festal® is given for deficiency of extracellular function of the pancreas, which often occurs in chronic pancreatitis and is accompanied by biliary insufficiency. It manifests with digestive disorders, flatulence, and a tendency to constipate.

The drug is also used in complex therapy for pancreatin:

Diffuse liver disorders, such as alcoholic and toxic lesions, and cirrhosis of the liver
Large bile acid losses in patients after cholecystectomy
Bile acid circulation disorders due to biliary dyskinesia, dysbacteriosis, and malabsorption
Disorders of neurohumoral regulation of biliary formation and biliary function in chronic gastrointestinal diseases, including chronic gastritis, duodenitis, and cholecystitis.

Festal® helps improve digestion in people with normal GI function if they have made mistakes in nutrition, have problems with mastication, prolonged immobilization, or are sedentary. The drug is also used to prepare for X-rays and ultrasonography

Recommendations for use, duration and volume of administration

Said medicinal agent is perorally, in whole, without nipping, during a meal or immediately after it and is recorded with a small volume of water.
Recommended dose for adults: one - two tablets, three times a day. A doctor determines how much dose is increased.

The use of this drug in children is prescribed by a doctor.
The duration of therapy can range from several days (for digestive disorders caused by errors in nutrition) to several months or years (for long-term maintenance therapy).
When preparing for X-ray or ultrasound examination: two tablets two to three times a day two to three days before the procedure.

  • Nosology pancreatin (ICD codes)
  • K29
  • Gastritis and duodenitis
  • K30
  • Functional dyspepsia (digestive disorder)
  • K63.8
  • Other specified diseases of intestine
  • K70
  • Alcoholic liver disease
  • K71
  • Hepatic toxicity
  • K74
  • Hepatic fibrosis and cirrhosis
  • K81.1
  • Chronic cholecystitis
  • K82.8
  • Other specified diseases of gallbladder and cystic duct (incl. dyskinesia)
  • K86.1
  • Other chronic pancreatitis
  • K90
  • Malabsorption disorders intestine
  • K91.5
  • Post cholecystectomy syndrome
  • R14
  • Flatulence and related conditions (incl. abdominal distention, eructation)
  • Z51.4
  • Preparatory procedures for follow-up treatment or examination, not elsewhere classified
  • Z72.4
  • Unacceptable diets and unhealthy eating habits
Features
Active substance
Pharmacological group
Formulation
Country of origin
Expiration Date
No reviews yet — your comment may be first.
All reviews 0
general rating